US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Humacyte, Inc.

2.19

-0.0500-2.23%

Volume:3.64M

Turnover:8.03M

Market Cap:339.71M

PE:-3.38

High:2.36

Open:2.16

Low:2.05

Close:2.24

Loading ...

Overview Company News Filings

Humacyte Surges 77% on FDA Approval for Symvess Vascular Repair Product

Humacyte Shares Soar 55.2% Premarket After FDA Approves Blood Vessel Implant

THOMSON REUTERS

Humacyte Price Target Raised to $15.00/Share From $12.00 by HC Wainwright & Co.

Humacyte Shares Surge 38% on FDA Approval of Symvess

Humacyte price target raised to $15 from $12 at H.C. Wainwright

Humacyte Gets FDA's Full Approval for Universally Implantable Bioengineered Human Tissue; Shares Soar Premarket

MT Newswires Live

BUZZ-Humacyte rises over 40% on FDA approval for blood vessel implant

US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'

Humacyte announces FDA approval for Symvess

BRIEF-Humacyte Announces FDA Approval Of Symvess For The Treatment Of Extremity Vascular Trauma

Humacyte Announces FDA Approval of Symvess™ (Acellular Tissue Engineered Vessel-Tyod) for the Treatment of Extremity Vascular Trauma

THOMSON REUTERS

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Individual investors who have a significant stake must be disappointed along with institutions after Humacyte, Inc.'s (NASDAQ:HUMA) market cap dropped by US$60m

Simply Wall St.

Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)

Insider Buyers At Humacyte Likely Disappointed With 17% Slide

Simply Wall St.

Humacyte Is Maintained at Buy by D. Boral Capital

Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

HUMA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HUMA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HUMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HUMA\",,,,,undefined,":{"symbol":"HUMA","market":"US","secType":"STK","nameCN":"Humacyte, Inc.","latestPrice":2.19,"timestamp":1747671050512,"preClose":2.24,"halted":0,"volume":3640696,"delay":0,"floatShares":121934449,"shares":155118816,"eps":-0.647002,"marketStatus":"Trading","change":-0.05,"latestTime":"05-19 12:10:51 EDT","open":2.155,"high":2.36,"low":2.0519,"amount":8028621.553545601,"amplitude":0.137545,"askPrice":2.2,"askSize":4383,"bidPrice":2.19,"bidSize":205,"shortable":3,"etf":0,"ttmEps":-0.647002,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747684800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.24,"preHourTrading":{"tag":"盘前","latestPrice":2.1793,"preClose":2.24,"latestTime":"09:29 EDT","volume":92404,"amount":199263.6170772,"timestamp":1747661379703},"postHourTrading":{"tag":"盘后","latestPrice":2.1799,"preClose":2.231331,"latestTime":"19:59 EDT","volume":114707,"amount":252314.9184,"timestamp":1747439994694},"volumeRatio":1.105509,"impliedVol":1.0421,"impliedVolPercentile":0.224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HUMA\",,,,,undefined,":{"symbol":"HUMA","floatShares":121934449,"roa":"-42.82%","roe":"-249.75%","lyrEps":-1.255082,"volumeRatio":1.105509,"shares":155118816,"dividePrice":0,"high":2.36,"amplitude":0.137545,"preClose":2.24,"low":2.0519,"week52Low":1.15,"pbRate":"9.43","psRate":"657.08","week52High":9.97,"institutionHeld":0,"latestPrice":2.19,"committee":-0.910636,"eps":-0.647002,"divideRate":0,"volume":3640696,"delay":0,"ttmEps":-0.647002,"open":2.155,"prevYearClose":5.05,"prevWeekClose":2.24,"prevMonthClose":1.45,"prevQuarterClose":1.705,"fiveDayClose":1.32,"twentyDayClose":1.45,"sixtyDayClose":3.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HUMA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1109225436","title":"Humacyte Surges 77% on FDA Approval for Symvess Vascular Repair Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1109225436","media":"Seeking Alpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109225436?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:10","pubTimestamp":1734703845,"startTime":"0","endTime":"0","summary":"Humacyte  shares climbed ~70% in the premarket on Friday after the bioengineered tissue maker announced the FDA approval of Symvess, an off-the-shelf, implantable vascular conduit indicated for arterial injury.According to the FDA labeling, Symvess will be available for adults with arterial injury in extremities. It will be indicated when an autologous vein graft is not feasible when there is a risk of near-term limb loss, and in other cases for urgent revascularization.“SYMVESS approval in this","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4389065-humacyte-stock-surges-symvess-fda-approval","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Humacyte Surges on FDA Approval for Symvess Vascular Repair Product","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1728464409321","symbols":["HUMA"],"gpt_icon":1},{"id":"2492410101","title":"Humacyte Shares Soar 55.2% Premarket After FDA Approves Blood Vessel Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2492410101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492410101?lang=en_us&edition=fundamental","pubTime":"2024-12-20 20:55","pubTimestamp":1734699337,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4N3NL0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2492414818","title":"Humacyte Price Target Raised to $15.00/Share From $12.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414818","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492414818?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:58","pubTimestamp":1734695880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HUMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 20, 2024 06:58 ET (11:58 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA"],"gpt_icon":0},{"id":"2492411414","title":"Humacyte Shares Surge 38% on FDA Approval of Symvess","url":"https://stock-news.laohu8.com/highlight/detail?id=2492411414","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492411414?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:56","pubTimestamp":1734695760,"startTime":"0","endTime":"0","summary":"Humacyte shares surged 38% in premarket trading a day after disclosing the Food and Drug Administration granted full approval of Symvess for adults.Shares were trading around $4.81. The stock is up 22% on the year.The biotechnology company said the approval applies to use of the treatment as a vascular conduit for extremity arterial injury when blood flow needs to urgently be restored to avoid imminent limb loss, and when a graft of a vein used to repair blood vessels isn't feasible.Symvess was used to repair many types of traumatic injuries including car accidents, gunshot wounds, blast wounds and industrial accidents, said Humacyte.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HUMA","BK4563"],"gpt_icon":0},{"id":"2492164044","title":"Humacyte price target raised to $15 from $12 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2492164044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492164044?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:15","pubTimestamp":1734693311,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Vernon Bernardino raised the firm’s price target on Humacyte (HUMA) to $15 from $12 and keeps a Buy rating on the shares af...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/humacyte-price-target-raised-to-15-from-12-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/humacyte-price-target-raised-to-15-from-12-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HUMA","BK4563"],"gpt_icon":0},{"id":"2492415023","title":"Humacyte Gets FDA's Full Approval for Universally Implantable Bioengineered Human Tissue; Shares Soar Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415023","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492415023?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:10","pubTimestamp":1734693028,"startTime":"0","endTime":"0","summary":"Humacyte  said late Thursday that the US Food and Drug Administration granted full approval for SYMVESS, a bioengineered human tissue designed to be universally implantable.Shares of the company rose more than 35% in recent premarket activity Friday.The approval is for SYMVESS' use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss and when autologous vein graft is not feasible.In clinical testing, SYMVESS was observed to have \"high rates of patency, or blood flow, and low rates of amputation and infection,\" the company said, adding that the commercial launch of the treatment is \"upcoming.\"Price: 4.70, Change: +1.24, Percent Change: +35.84","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","HUMA","BK4139"],"gpt_icon":1},{"id":"2492415487","title":"BUZZ-Humacyte rises over 40% on FDA approval for blood vessel implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492415487?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:04","pubTimestamp":1734692641,"startTime":"0","endTime":"0","summary":"BUZZ-Humacyte rises over 40% on FDA approval for blood vessel implant** Biotech company Humacyte's HUMA.O shares rise ~44.2% to $4.99 premarket** HUMA, late on Thursday, said the U.S. FDA approved its implant Symvess for patients with extreme blood vessel injury** The approval was based on clinical tests where Symvess showed high rates of blood flow and low rates of infection ** HUMA says the implant can be used as a channel in patients who need to have their blood flow restored to avoid imminent limb loss** Up to last close, stock up 21.8% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4N3NL0NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4563","BK4139"],"gpt_icon":0},{"id":"2492418148","title":"US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'","url":"https://stock-news.laohu8.com/highlight/detail?id=2492418148","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492418148?lang=en_us&edition=fundamental","pubTime":"2024-12-20 18:37","pubTimestamp":1734691077,"startTime":"0","endTime":"0","summary":"U.S. futures declined on Friday, ahead of the &#39;Triple Witching&#39; hour, which is expected to see $6.6 trillion options expire, for the quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42611748/us-stocks-to-open-lower-as-traders-brace-for-triple-witching-hour-analyst-says-end-of-the-year-recovery-would-not-surprise-anyone","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","USJW.SI","OEF","VOO","LU1303367103.USD","NQmain","QQQ","FDX","QLD","IVV","SH","LU0786609619.USD","NKE","WGO","QID","SPXU","BK4593","BK4099","BK4504","LU1571399168.USD","LU0251142724.SGD","BK4563","LU0128525689.USD","SSO","PSQ","BK4533","NVIW.SI",".SPX","LU0052756011.USD","HUMA","TQQQ","BK4517","SPY",".IXIC","UPRO","BK4581","LU2098885051.SGD","CCL","OEX","LU0742534661.SGD","SQQQ","SDS","BK4566","USAW.SI","TSYW.SI","PBM","ESmain","LU1267930227.SGD","BK4585"],"gpt_icon":1},{"id":"2492490737","title":"Humacyte announces FDA approval for Symvess","url":"https://stock-news.laohu8.com/highlight/detail?id=2492490737","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492490737?lang=en_us&edition=fundamental","pubTime":"2024-12-20 18:15","pubTimestamp":1734689713,"startTime":"0","endTime":"0","summary":"Humacyte (HUMA) announced that the FDA has granted a full approval for Symvess for use in adults as a vascular conduit for extremity arterial injur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/humacyte-announces-fda-approval-for-symvess?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/humacyte-announces-fda-approval-for-symvess?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4139","HUMA"],"gpt_icon":0},{"id":"2492452511","title":"BRIEF-Humacyte Announces FDA Approval Of Symvess For The Treatment Of Extremity Vascular Trauma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492452511","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492452511?lang=en_us&edition=fundamental","pubTime":"2024-12-20 11:51","pubTimestamp":1734666695,"startTime":"0","endTime":"0","summary":"Dec 19 (Reuters) - Humacyte Inc   :   * HUMACYTE ANNOUNCES FDA APPROVAL OF SYMVESS™ (ACELLULAR TISSUE ENGINEERED VESSEL-TYOD) FOR THE TREATMENT OF EXTREMITY VASCULAR TRAUMASource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BRIEF-Humacyte Announces FDA Approval Of Symvess For The Treatment Of Extremity Vascular Trauma","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","HUMA","BK4139"],"gpt_icon":0},{"id":"2492452366","title":"Humacyte Announces FDA Approval of Symvess™ (Acellular Tissue Engineered Vessel-Tyod) for the Treatment of Extremity Vascular Trauma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492452366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492452366?lang=en_us&edition=fundamental","pubTime":"2024-12-20 11:47","pubTimestamp":1734666433,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUA3M0H2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","HUMA"],"gpt_icon":0},{"id":"2492569457","title":"Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492569457","media":"GlobeNewswire","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492569457?lang=en_us&edition=fundamental","pubTime":"2024-12-20 11:47","pubTimestamp":1734666420,"startTime":"0","endTime":"0","summary":"– SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair –。– In clinical testing SYMVESS was observed to have high rates of patency, or blood flow, and low rates of amputation and infection –。– Highly experienced sales team already recruited and trained in preparation for commercial launch –。DURHAM, N.C., Dec. 19, 2024  -- Humacyte, Inc. , a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the U.S. Food and Drug Administration  has granted a full approval for SYMVESS  for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and when autologous vein graft is not feasible.“I believe that SYMVESS will revolutionize vascular trauma care and be profoundly beneficial to our patients,” said Rishi Kundi, MD, Surgical Critical C","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-announces-fda-approval-symvess-034700671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma","news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMA","HUMAW"],"gpt_icon":0},{"id":"2492364741","title":"Individual investors who have a significant stake must be disappointed along with institutions after Humacyte, Inc.'s (NASDAQ:HUMA) market cap dropped by US$60m","url":"https://stock-news.laohu8.com/highlight/detail?id=2492364741","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492364741?lang=en_us&edition=fundamental","pubTime":"2024-12-19 00:39","pubTimestamp":1734539956,"startTime":"0","endTime":"0","summary":"Humacyte's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public. A look at the shareholders of Humacyte, Inc.  can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 46% ownership. That is, the group stands to benefit the most if the stock rises .Following a 11% decrease in the stock price last week, individual investors suffered the most losses, but institutions who own 28% stock also took a hit.Let's delve deeper into each type of owner of Humacyte, beginning with the chart below.NasdaqGS:HUMA Earnings and Revenue Growth December 18th 2024. Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/individual-investors-significant-stake-must-163916947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","USJW.SI","LU2095319765.USD","NDAQ","QID","USAW.SI","BK4585","BK4563","PSQ",".IXIC","TSYW.SI","LU2210150020.SGD","TQQQ","BK4112","HUMAW","IE00BKPKM429.USD","IE00B3QW5Z07.USD","MNQmain","LU2210149790.SGD","QLD","BK4139","BK4588","NVIW.SI","NQmain","IE00BGHQF748.EUR","HUMA","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2485505372","title":"Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485505372","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485505372?lang=en_us&edition=fundamental","pubTime":"2024-11-22 21:00","pubTimestamp":1732280400,"startTime":"0","endTime":"0","summary":"Presentation Title: Results of a Phase 3 Study Comparing Efficacy and Safety of Humacyte Tissue-Engineered Vessel with Autologous AV Fistulas in Patients with End Stage Renal Disease. Presenter: Dr. Charles Keith Ozaki, MD, Vascular Surgeon and Director of Vascular Surgery Research at Brigham and Women’s Hospital; John A. Mannick Professor of Surgery at Harvard Medical School. Session Date/Time: Saturday, November 23, 2024, 2:15 – 2:22 PM ET. For more information on the 51stAnnual Symposium on Vascular and Endovascular Issues, Techniques and Horizons , please click here.The ATEV is an investigational product and has not been approved for sale by the FDA or any other regulatory agency.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-present-efficacy-safety-results-130000648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMA","HUMAW"],"gpt_icon":0},{"id":"2485414773","title":"Insider Buyers At Humacyte Likely Disappointed With 17% Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2485414773","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485414773?lang=en_us&edition=fundamental","pubTime":"2024-11-22 00:15","pubTimestamp":1732205746,"startTime":"0","endTime":"0","summary":"Insiders who acquired US$775.1k worth of Humacyte, Inc.'s  stock at an average price of US$6.64 in the past 12 months may be dismayed by the recent 17% price decline. Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth US$514.8k, which is not great.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.The Last 12 Months Of Insider Transactions At Humacyte. Insider purchases may have been minimal, in the last three months, but there was no selling at all. Overall the buying isn't worth writing home about. But ins","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-buyers-humacyte-likely-disappointed-161546718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","HUMA","HUMAW","BK4139"],"gpt_icon":1},{"id":"2485549588","title":"Humacyte Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2485549588","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485549588?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:05","pubTimestamp":1732194300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HUMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2024 08:05 ET (13:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA"],"gpt_icon":0},{"id":"2485496697","title":"Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2485496697","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485496697?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:00","pubTimestamp":1732194000,"startTime":"0","endTime":"0","summary":"– In two studies the acellular tissue engineered vessel  provided benefits in terms of patency, limb salvage, and infection resistance compared to current synthetic graft treatment benchmarks –。– Results were published in a premier peer-reviewed surgical journal sponsored by the American Medical Association –。The JAMA Surgery publication described the results of two studies in which the ATEV was evaluated in patients with extremity vascular trauma. The V005 clinical trial was a single-arm study conducted in the United States and Israel in patients with arterial injuries resulting from gun shots, workplace injuries, car accidents, or other traumatic events for whom the standard of care, saphenous vein, was not feasible or available to use as a bypass graft. The V017 single-arm clinical trial evaluated patient outcomes from a humanitarian program which patients with wartime injuries were treated in Ukraine. As single-arm studies, the comparators for the ATEV results were a systematic lit","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ynokd824_ifMQUhmmQ3DyA--~B/aD0zOTY7dz0yMDg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b5d13f4f1b8227362f0c6d3e1c1db49a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-clinical-results-highlighting-benefit-130000412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4563","HUMA","HUMAW"],"gpt_icon":1},{"id":"2485178847","title":"HUMA LAWSUIT ALERT: Levi & Korsinsky LLP Notifies Humacyte, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2485178847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485178847?lang=en_us&edition=fundamental","pubTime":"2024-11-21 04:40","pubTimestamp":1732135204,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: A class action securities lawsuit was filed against Humacyte, Inc. (HUMA) that seeks to recover losses of Humacyte, Inc. shareholders ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/huma-lawsuit-alert-levi-korsinsky-llp-notifies-humacyte-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/huma-lawsuit-alert-levi-korsinsky-llp-notifies-humacyte-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HUMA","ISBC","BK4211","BK4139","BK4563"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":98,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HUMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"HUMA","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-03-28","symbol":"HUMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2024-11-08","symbol":"HUMA","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-08-13","symbol":"HUMA","fiscalQuarterEnding":"2024/06","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2024-05-10","symbol":"HUMA","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HUMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HUMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.7143,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1725940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HUMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HUMA","date":"2025-05-16","current":-3.774812,"percent":0.60989,"low":-42.920684,"twenty":-13.703315,"median":-4.672091,"eighty":-1.683404,"high":18.870018,"avg":-5.97188,"sd":10.434869,"marketCap":293174562},"quantilePoints":[{"date":"2021-08-27","current":-18.172424,"twenty":-17.803017,"median":-17.248908,"eighty":-16.694798,"marketCap":1256641284},{"date":"2021-09-03","current":-19.946088,"twenty":-22.569056,"median":-19.946088,"eighty":-18.371508,"marketCap":1425566834},{"date":"2021-09-10","current":-20.003735,"twenty":-21.070217,"median":-19.946088,"eighty":-18.749899,"marketCap":1429686969},{"date":"2021-09-17","current":-20.609036,"twenty":-22.511408,"median":-20.126237,"eighty":-19.167844,"marketCap":1472948391},{"date":"2021-09-24","current":-18.086951,"twenty":-21.070217,"median":-20.003735,"eighty":-18.749899,"marketCap":1292692469},{"date":"2021-10-01","current":-15.89634,"twenty":-20.609036,"median":-19.881234,"eighty":-18.086951,"marketCap":1136127325},{"date":"2021-10-08","current":-15.838692,"twenty":-20.479328,"median":-19.095785,"eighty":-16.325391,"marketCap":1132007190},{"date":"2021-10-15","current":-14.728975,"twenty":-20.133443,"median":-18.288218,"eighty":-15.305452,"marketCap":1052694584},{"date":"2021-10-22","current":-13.979556,"twenty":-20.133443,"median":-18.086951,"eighty":-14.728975,"marketCap":999132824},{"date":"2021-10-29","current":-13.114841,"twenty":-20.119031,"median":-16.970028,"eighty":-14.339854,"marketCap":937330794},{"date":"2021-11-05","current":-15.507218,"twenty":-20.003735,"median":-15.953988,"eighty":-14.411913,"marketCap":1108316411},{"date":"2021-11-12","current":-14.930742,"twenty":-19.9605,"median":-15.766633,"eighty":-14.411913,"marketCap":1067115058},{"date":"2021-11-19","current":-13.226623,"twenty":-19.946088,"median":-15.507218,"eighty":-14.181322,"marketCap":1127887054},{"date":"2021-11-26","current":-13.26286,"twenty":-19.842322,"median":-15.334276,"eighty":-14.005323,"marketCap":1130977156},{"date":"2021-12-03","current":-12.550193,"twenty":-19.297551,"median":-15.204569,"eighty":-13.340166,"marketCap":1070205159},{"date":"2021-12-10","current":-12.308611,"twenty":-19.110197,"median":-14.959566,"eighty":-13.111959,"marketCap":1049604482},{"date":"2021-12-17","current":-10.520903,"twenty":-18.819076,"median":-14.829859,"eighty":-12.791775,"marketCap":897159474},{"date":"2021-12-23","current":-9.373388,"twenty":-18.542367,"median":-14.476767,"eighty":-12.594979,"marketCap":799306259},{"date":"2021-12-31","current":-8.757353,"twenty":-18.26506,"median":-14.411913,"eighty":-12.468055,"marketCap":746774534},{"date":"2022-01-07","current":-7.549442,"twenty":-18.12114,"median":-14.267794,"eighty":-12.199899,"marketCap":643771150},{"date":"2022-01-14","current":-7.04212,"twenty":-18.086951,"median":-14.152499,"eighty":-10.520903,"marketCap":600509728},{"date":"2022-01-21","current":-6.305294,"twenty":-18.075421,"median":-14.011765,"eighty":-9.520753,"marketCap":537677664},{"date":"2022-01-28","current":-5.616785,"twenty":-17.718006,"median":-13.878895,"eighty":-9.112479,"marketCap":478965735},{"date":"2022-02-04","current":-6.305294,"twenty":-17.017587,"median":-13.26286,"eighty":-8.757353,"marketCap":537677664},{"date":"2022-02-11","current":-6.691826,"twenty":-16.569495,"median":-13.164693,"eighty":-7.445562,"marketCap":570638747},{"date":"2022-02-18","current":-6.486481,"twenty":-16.17683,"median":-13.081674,"eighty":-7.131506,"marketCap":553128172},{"date":"2022-02-25","current":-6.933408,"twenty":-15.942458,"median":-12.803854,"eighty":-6.964813,"marketCap":591239424},{"date":"2022-03-04","current":-6.534797,"twenty":-15.88481,"median":-12.666028,"eighty":-6.93824,"marketCap":557248307},{"date":"2022-03-11","current":-6.873012,"twenty":-15.809868,"median":-12.509541,"eighty":-6.885091,"marketCap":586089254},{"date":"2022-03-18","current":-7.71855,"twenty":-15.668632,"median":-12.465639,"eighty":-6.875428,"marketCap":658191623},{"date":"2022-03-25","current":-7.791025,"twenty":-15.553336,"median":-12.260294,"eighty":-6.885091,"marketCap":664371826},{"date":"2022-04-01","current":-27.815942,"twenty":-15.88481,"median":-12.381086,"eighty":-6.894754,"marketCap":736482689},{"date":"2022-04-08","current":-25.870771,"twenty":-17.112705,"median":-12.489797,"eighty":-6.93824,"marketCap":684980403},{"date":"2022-04-14","current":-28.671817,"twenty":-18.086951,"median":-12.550193,"eighty":-6.957566,"marketCap":759143695},{"date":"2022-04-22","current":-27.621425,"twenty":-19.095785,"median":-12.72534,"eighty":-6.993803,"marketCap":731332461},{"date":"2022-04-29","current":-27.543618,"twenty":-19.9605,"median":-12.900487,"eighty":-7.04212,"marketCap":729272369},{"date":"2022-05-06","current":-24.431345,"twenty":-20.133443,"median":-13.107635,"eighty":-7.066278,"marketCap":646868712},{"date":"2022-05-13","current":-21.267862,"twenty":-20.479328,"median":-13.226623,"eighty":-7.114594,"marketCap":553134551},{"date":"2022-05-20","current":-18.653935,"twenty":-20.307583,"median":-13.619194,"eighty":-7.126674,"marketCap":485151534},{"date":"2022-05-27","current":-21.782726,"twenty":-20.307583,"median":-13.979556,"eighty":-7.126674,"marketCap":566525146},{"date":"2022-06-03","current":-24.238234,"twenty":-21.109746,"median":-14.123675,"eighty":-7.136337,"marketCap":630387980},{"date":"2022-06-10","current":-16.198427,"twenty":-20.701272,"median":-14.210146,"eighty":-7.167743,"marketCap":421288699},{"date":"2022-06-17","current":-14.851859,"twenty":-20.50527,"median":-14.339854,"eighty":-7.194316,"marketCap":386267145},{"date":"2022-06-24","current":-13.148846,"twenty":-20.376281,"median":-14.257784,"eighty":-7.213643,"marketCap":341975179},{"date":"2022-07-01","current":-13.030031,"twenty":-20.265913,"median":-14.199751,"eighty":-7.259544,"marketCap":338885041},{"date":"2022-07-08","current":-14.099365,"twenty":-20.196257,"median":-14.166911,"eighty":-7.288534,"marketCap":366696276},{"date":"2022-07-15","current":-13.861735,"twenty":-20.133443,"median":-14.099365,"eighty":-7.319939,"marketCap":360516002},{"date":"2022-07-22","current":-13.643908,"twenty":-20.127678,"median":-14.01596,"eighty":-7.389998,"marketCap":354850750},{"date":"2022-07-29","current":-13.782525,"twenty":-20.072913,"median":-13.940945,"eighty":-7.445562,"marketCap":358455910},{"date":"2022-08-05","current":-13.861735,"twenty":-19.986441,"median":-13.870315,"eighty":-7.491463,"marketCap":360516002},{"date":"2022-08-12","current":16.960989,"twenty":-19.954735,"median":-13.861735,"eighty":-7.491463,"marketCap":475891429},{"date":"2022-08-19","current":16.520444,"twenty":-19.894205,"median":-13.861735,"eighty":-7.288534,"marketCap":463530613},{"date":"2022-08-26","current":15.382369,"twenty":-19.748318,"median":-13.82213,"eighty":-7.153248,"marketCap":431598504},{"date":"2022-09-02","current":16.006474,"twenty":-19.630663,"median":-13.802328,"eighty":-7.085604,"marketCap":449109661},{"date":"2022-09-09","current":16.557156,"twenty":-19.598827,"median":-13.762722,"eighty":-6.964813,"marketCap":464560681},{"date":"2022-09-16","current":14.501278,"twenty":-19.485448,"median":-13.703315,"eighty":-6.875428,"marketCap":406876871},{"date":"2022-09-23","current":12.812522,"twenty":-19.153432,"median":-13.634006,"eighty":-6.815033,"marketCap":359493742},{"date":"2022-09-30","current":11.968144,"twenty":-19.04702,"median":-13.5845,"eighty":-6.682163,"marketCap":335802177},{"date":"2022-10-07","current":11.527599,"twenty":-18.844038,"median":-13.406278,"eighty":-6.546876,"marketCap":323441361},{"date":"2022-10-14","current":11.564311,"twenty":-18.804434,"median":-13.359493,"eighty":-6.486481,"marketCap":324471429},{"date":"2022-10-21","current":12.261841,"twenty":-18.76818,"median":-13.244741,"eighty":-6.356027,"marketCap":344042722},{"date":"2022-10-28","current":13.069507,"twenty":-18.746548,"median":-13.188451,"eighty":-6.102365,"marketCap":366704218},{"date":"2022-11-04","current":12.07828,"twenty":-18.717303,"median":-13.107635,"eighty":-5.682012,"marketCap":338892381},{"date":"2022-11-11","current":9.639204,"twenty":-18.638093,"median":-13.030031,"eighty":11.527599,"marketCap":331010259},{"date":"2022-11-18","current":8.798401,"twenty":-18.540583,"median":-12.798127,"eighty":11.179949,"marketCap":302137090},{"date":"2022-11-25","current":9.519089,"twenty":-18.404013,"median":-12.728325,"eighty":9.819376,"marketCap":326885521},{"date":"2022-12-02","current":9.459032,"twenty":-18.337095,"median":-12.624836,"eighty":9.789347,"marketCap":324823152},{"date":"2022-12-09","current":9.008602,"twenty":-18.172424,"median":-12.499669,"eighty":9.72929,"marketCap":309355383},{"date":"2022-12-16","current":7.477139,"twenty":-18.086951,"median":-12.45356,"eighty":9.72929,"marketCap":256764967},{"date":"2022-12-23","current":6.906595,"twenty":-18.086951,"median":-12.242176,"eighty":9.639204,"marketCap":237172460},{"date":"2022-12-30","current":6.33605,"twenty":-18.065278,"median":-11.499311,"eighty":9.615181,"marketCap":217579952},{"date":"2023-01-06","current":6.756451,"twenty":-18.05882,"median":-10.653773,"eighty":9.555123,"marketCap":232016537},{"date":"2023-01-13","current":7.507168,"twenty":-18.035404,"median":-9.808236,"eighty":9.483055,"marketCap":257796152},{"date":"2023-01-20","current":7.537197,"twenty":-17.782625,"median":-9.506258,"eighty":9.459032,"marketCap":258827337},{"date":"2023-01-27","current":8.347971,"twenty":-17.426181,"median":-9.409625,"eighty":9.44702,"marketCap":286669321},{"date":"2023-02-03","current":9.699261,"twenty":-17.338838,"median":-8.79359,"eighty":9.44702,"marketCap":333072629},{"date":"2023-02-10","current":8.648258,"twenty":-17.200115,"median":-8.757353,"eighty":9.459032,"marketCap":296981167},{"date":"2023-02-17","current":9.398974,"twenty":-17.006023,"median":-7.791025,"eighty":9.459032,"marketCap":322760782},{"date":"2023-02-24","current":8.738344,"twenty":-16.650863,"median":-7.778945,"eighty":9.453026,"marketCap":300074721},{"date":"2023-03-03","current":9.429003,"twenty":-16.299998,"median":-7.652115,"eighty":9.429003,"marketCap":323791967},{"date":"2023-03-10","current":8.167799,"twenty":-16.149539,"median":-7.549442,"eighty":9.453026,"marketCap":280482213},{"date":"2023-03-17","current":8.82843,"twenty":-15.942458,"median":-7.398454,"eighty":9.429003,"marketCap":303168275},{"date":"2023-03-24","current":-25.130612,"twenty":-15.942458,"median":-7.295781,"eighty":9.422997,"marketCap":300687777},{"date":"2023-03-31","current":-26.685083,"twenty":-17.097287,"median":-7.44677,"eighty":9.398974,"marketCap":319287020},{"date":"2023-04-06","current":-25.56241,"twenty":-17.426181,"median":-7.555481,"eighty":9.398974,"marketCap":305854233},{"date":"2023-04-14","current":-28.584992,"twenty":-18.086951,"median":-7.694392,"eighty":9.368946,"marketCap":342019430},{"date":"2023-04-21","current":-28.757711,"twenty":-18.404013,"median":-7.784985,"eighty":9.27886,"marketCap":344086012},{"date":"2023-04-28","current":-27.894116,"twenty":-18.749899,"median":-8.141319,"eighty":9.27886,"marketCap":333753099},{"date":"2023-05-05","current":-37.998191,"twenty":-19.095785,"median":-8.775472,"eighty":9.27886,"marketCap":454648352},{"date":"2023-05-12","current":-36.659618,"twenty":-19.646225,"median":-8.93854,"eighty":9.27886,"marketCap":438632330},{"date":"2023-05-19","current":-14.94797,"twenty":-19.607321,"median":-9.451901,"eighty":9.248831,"marketCap":435015809},{"date":"2023-05-26","current":-12.817618,"twenty":-19.564849,"median":-9.542495,"eighty":9.218802,"marketCap":373018307},{"date":"2023-06-02","current":-12.000983,"twenty":-19.247245,"median":-10.520903,"eighty":9.218802,"marketCap":349252597},{"date":"2023-06-09","current":-15.089993,"twenty":-19.110197,"median":-10.810802,"eighty":9.218802,"marketCap":439148976},{"date":"2023-06-16","current":-11.903568,"twenty":-18.900724,"median":-12.000983,"eighty":9.218802,"marketCap":346417630},{"date":"2023-06-23","current":-10.41118,"twenty":-18.828197,"median":-11.441638,"eighty":9.200785,"marketCap":302986166},{"date":"2023-06-30","current":-10.730978,"twenty":-18.796513,"median":-10.786643,"eighty":9.176762,"marketCap":312292908},{"date":"2023-07-07","current":-9.771586,"twenty":-18.76818,"median":-10.730978,"eighty":9.152739,"marketCap":284372682},{"date":"2023-07-14","current":-11.335039,"twenty":-18.746548,"median":-10.659911,"eighty":9.128716,"marketCap":329872311},{"date":"2023-07-21","current":-10.730978,"twenty":-18.717303,"median":-10.766511,"eighty":9.12271,"marketCap":312292908},{"date":"2023-07-28","current":-9.842652,"twenty":-18.638093,"median":-10.677678,"eighty":9.092682,"marketCap":286440846},{"date":"2023-08-04","current":-11.086308,"twenty":-18.540583,"median":-10.730978,"eighty":9.068659,"marketCap":322633733},{"date":"2023-08-11","current":-12.116766,"twenty":-18.390629,"median":-10.766511,"eighty":9.062653,"marketCap":352622125},{"date":"2023-08-18","current":-4.129169,"twenty":-18.304161,"median":-10.730978,"eighty":9.032624,"marketCap":366158154},{"date":"2023-08-25","current":-4.234147,"twenty":-18.155329,"median":-10.624378,"eighty":9.008602,"marketCap":375467260},{"date":"2023-09-01","current":-4.467434,"twenty":-18.086951,"median":-10.520903,"eighty":9.008602,"marketCap":396154161},{"date":"2023-09-08","current":-4.432441,"twenty":-18.086951,"median":-10.41118,"eighty":9.008602,"marketCap":393051126},{"date":"2023-09-15","current":-4.129169,"twenty":-18.05986,"median":-10.322347,"eighty":8.948544,"marketCap":366158154},{"date":"2023-09-22","current":-3.417645,"twenty":-18.058127,"median":-10.269048,"eighty":8.918516,"marketCap":303063105},{"date":"2023-09-29","current":-3.405981,"twenty":-18.020255,"median":-10.215749,"eighty":8.918516,"marketCap":302028760},{"date":"2023-10-06","current":-3.301002,"twenty":-17.426181,"median":-10.091383,"eighty":8.82843,"marketCap":292719654},{"date":"2023-10-13","current":-2.857758,"twenty":-17.426181,"median":-9.878185,"eighty":8.798401,"marketCap":253414542},{"date":"2023-10-20","current":-2.72945,"twenty":-17.207824,"median":-9.771586,"eighty":8.738344,"marketCap":242036746},{"date":"2023-10-27","current":-2.437842,"twenty":-17.200115,"median":-9.542495,"eighty":8.738344,"marketCap":216178119},{"date":"2023-11-03","current":-2.461171,"twenty":-17.006023,"median":-9.451901,"eighty":8.726332,"marketCap":218246809},{"date":"2023-11-10","current":-2.557224,"twenty":-16.569495,"median":-8.93854,"eighty":8.708315,"marketCap":228590260},{"date":"2023-11-17","current":-2.827202,"twenty":-16.274605,"median":-8.775472,"eighty":8.696303,"marketCap":252723624},{"date":"2023-11-24","current":-3.001006,"twenty":-16.149539,"median":-8.449336,"eighty":8.67228,"marketCap":268259913},{"date":"2023-12-01","current":-3.070527,"twenty":-15.942458,"median":-7.791025,"eighty":8.642252,"marketCap":274474428},{"date":"2023-12-08","current":-3.267504,"twenty":-15.88481,"median":-7.706471,"eighty":8.606218,"marketCap":292082221},{"date":"2023-12-15","current":-3.615111,"twenty":-15.809868,"median":-7.561521,"eighty":8.558172,"marketCap":323154798},{"date":"2023-12-22","current":-3.255918,"twenty":-15.668632,"median":-7.44677,"eighty":8.552166,"marketCap":291046469},{"date":"2023-12-29","current":-3.441308,"twenty":-15.590807,"median":-7.356177,"eighty":8.534149,"marketCap":307618510},{"date":"2024-01-05","current":-3.105288,"twenty":-15.541807,"median":-7.289741,"eighty":8.50412,"marketCap":277581686},{"date":"2024-01-12","current":-3.128462,"twenty":-15.484159,"median":-7.199148,"eighty":8.42004,"marketCap":279653191},{"date":"2024-01-19","current":-3.001006,"twenty":-15.426512,"median":-7.138753,"eighty":8.33596,"marketCap":268259913},{"date":"2024-01-26","current":-3.476069,"twenty":-15.332844,"median":-7.120634,"eighty":8.275902,"marketCap":310725768},{"date":"2024-02-02","current":-3.951131,"twenty":-15.322785,"median":-7.04212,"eighty":8.215845,"marketCap":353191622},{"date":"2024-02-09","current":-3.632492,"twenty":-15.293922,"median":-6.945487,"eighty":8.143776,"marketCap":324708427},{"date":"2024-02-16","current":-5.167755,"twenty":-15.246978,"median":-6.885091,"eighty":8.035673,"marketCap":461945641},{"date":"2024-02-23","current":-4.988158,"twenty":-15.243673,"median":-6.848854,"eighty":7.987627,"marketCap":445891477},{"date":"2024-03-01","current":-5.692386,"twenty":-15.208303,"median":-6.818657,"eighty":7.897541,"marketCap":508842363},{"date":"2024-03-08","current":-4.352632,"twenty":-15.196511,"median":-6.703905,"eighty":7.897541,"marketCap":389081787},{"date":"2024-03-15","current":-4.206213,"twenty":-15.161333,"median":-6.661628,"eighty":7.807455,"marketCap":375993408},{"date":"2024-03-22","current":-4.791889,"twenty":-15.089993,"median":-6.595193,"eighty":7.807455,"marketCap":428346921},{"date":"2024-03-28","current":-3.329731,"twenty":-15.02024,"median":-6.534797,"eighty":7.783432,"marketCap":368854293},{"date":"2024-04-05","current":-3.353987,"twenty":-14.9771,"median":-6.486481,"eighty":7.753403,"marketCap":371541231},{"date":"2024-04-12","current":-3.246487,"twenty":-14.961788,"median":-6.389848,"eighty":7.699351,"marketCap":359632858},{"date":"2024-04-19","current":-3.859235,"twenty":-14.950289,"median":-6.329453,"eighty":7.567226,"marketCap":427510583},{"date":"2024-04-26","current":-4.192483,"twenty":-14.934188,"median":-6.208661,"eighty":7.537197,"marketCap":464426539},{"date":"2024-05-03","current":-4.730006,"twenty":-14.930742,"median":-6.069751,"eighty":7.513174,"marketCap":523971153},{"date":"2024-05-10","current":-4.859006,"twenty":-14.867636,"median":-5.692386,"eighty":7.507168,"marketCap":538261275},{"date":"2024-05-17","current":-7.232733,"twenty":-14.851859,"median":-6.003317,"eighty":7.483145,"marketCap":764521546},{"date":"2024-05-24","current":-8.122742,"twenty":-14.843533,"median":-6.075791,"eighty":7.477139,"marketCap":858598185},{"date":"2024-05-31","current":-10.252004,"twenty":-14.773966,"median":-6.208661,"eighty":7.477139,"marketCap":1083667612},{"date":"2024-06-07","current":-8.246667,"twenty":-14.711247,"median":-6.329453,"eighty":7.477139,"marketCap":871697463},{"date":"2024-06-14","current":-8.111476,"twenty":-14.699428,"median":-6.377769,"eighty":7.345013,"marketCap":857407341},{"date":"2024-06-21","current":-5.903352,"twenty":-14.69823,"median":-6.407966,"eighty":7.098778,"marketCap":624002009},{"date":"2024-06-28","current":-5.294991,"twenty":-14.695835,"median":-6.407966,"eighty":7.002687,"marketCap":559696459},{"date":"2024-07-05","current":-6.387787,"twenty":-14.624823,"median":-6.387787,"eighty":6.906595,"marketCap":675208281},{"date":"2024-07-12","current":-7.266531,"twenty":-14.506729,"median":-6.387787,"eighty":6.846537,"marketCap":768094076},{"date":"2024-07-15","current":-7.874891,"twenty":-14.499143,"median":-6.388818,"eighty":6.816509,"marketCap":832399627},{"date":"2024-08-02","current":-9.711239,"twenty":-14.491558,"median":-6.389848,"eighty":6.78648,"marketCap":1026507122},{"date":"2024-08-09","current":-9.012751,"twenty":-14.472443,"median":-6.465299,"eighty":6.66036,"marketCap":952674824},{"date":"2024-08-16","current":-5.247142,"twenty":-14.458031,"median":-6.444117,"eighty":6.600303,"marketCap":732815889},{"date":"2024-08-23","current":-5.469334,"twenty":-14.42056,"median":-6.388818,"eighty":6.55526,"marketCap":763847180},{"date":"2024-08-30","current":-5.255688,"twenty":-14.354266,"median":-6.387787,"eighty":6.450159,"marketCap":734009400},{"date":"2024-09-06","current":-4.683117,"twenty":-14.313912,"median":-6.353611,"eighty":6.372084,"marketCap":654044148},{"date":"2024-09-13","current":-4.802759,"twenty":-14.282662,"median":-6.256977,"eighty":6.33605,"marketCap":670753305},{"date":"2024-09-20","current":-4.65748,"twenty":-14.264014,"median":-6.075791,"eighty":6.33605,"marketCap":650463614},{"date":"2024-09-27","current":-4.674571,"twenty":-14.246496,"median":-6.05676,"eighty":6.281998,"marketCap":652850637},{"date":"2024-10-04","current":-4.512201,"twenty":-14.226496,"median":-6.007722,"eighty":6.209929,"marketCap":630173924},{"date":"2024-10-11","current":-4.96873,"twenty":-14.196065,"median":-5.920251,"eighty":6.113838,"marketCap":693932828},{"date":"2024-10-18","current":-4.350996,"twenty":-14.164028,"median":-5.691526,"eighty":1.033597,"marketCap":607660098},{"date":"2024-10-25","current":-5.210452,"twenty":-14.150452,"median":-5.612421,"eighty":-2.335196,"marketCap":727691722},{"date":"2024-10-31","current":-4.610623,"twenty":-14.138923,"median":-5.533428,"eighty":-2.358525,"marketCap":643919651},{"date":"2024-11-08","current":-4.709103,"twenty":-14.113951,"median":-5.469334,"eighty":-2.402849,"marketCap":657673274},{"date":"2024-11-15","current":-3.984902,"twenty":-14.097951,"median":-5.374398,"eighty":-2.447174,"marketCap":609159960},{"date":"2024-11-22","current":-3.686655,"twenty":-14.065559,"median":-5.294991,"eighty":-2.465837,"marketCap":563567959},{"date":"2024-11-29","current":-3.804494,"twenty":-14.020155,"median":-5.255688,"eighty":-2.489165,"marketCap":581581547},{"date":"2024-12-06","current":-3.779243,"twenty":-14.018477,"median":-5.238596,"eighty":-2.555034,"marketCap":577721493},{"date":"2024-12-13","current":-3.434145,"twenty":-14.005323,"median":-5.210452,"eighty":-2.563675,"marketCap":524967414},{"date":"2024-12-20","current":-2.912289,"twenty":-13.971834,"median":-5.168992,"eighty":-2.592993,"marketCap":445192954},{"date":"2024-12-27","current":-4.452604,"twenty":-13.940945,"median":-5.132962,"eighty":-2.607051,"marketCap":680656280},{"date":"2025-01-03","current":-4.360017,"twenty":-13.93135,"median":-5.121166,"eighty":-2.630319,"marketCap":666502747},{"date":"2025-01-10","current":-3.939166,"twenty":-13.92256,"median":-5.100627,"eighty":-2.650133,"marketCap":602168505},{"date":"2025-01-17","current":-3.770826,"twenty":-13.894657,"median":-5.017126,"eighty":-2.697538,"marketCap":576434808},{"date":"2025-01-24","current":-3.863413,"twenty":-13.878895,"median":-4.988158,"eighty":-2.725532,"marketCap":590588341},{"date":"2025-01-31","current":-3.972834,"twenty":-13.872031,"median":-4.962243,"eighty":-2.745377,"marketCap":607315244},{"date":"2025-02-07","current":-3.594068,"twenty":-13.861735,"median":-4.906061,"eighty":-2.786001,"marketCap":549414426},{"date":"2025-02-14","current":-3.299472,"twenty":-13.861735,"median":-4.873501,"eighty":-2.815767,"marketCap":504380457},{"date":"2025-02-21","current":-3.156383,"twenty":-13.861735,"median":-4.86258,"eighty":-2.823652,"marketCap":482506815},{"date":"2025-02-28","current":-2.836536,"twenty":-13.861735,"median":-4.861298,"eighty":-2.813434,"marketCap":433612791},{"date":"2025-03-07","current":-2.491438,"twenty":-13.853814,"median":-4.8503,"eighty":-2.724226,"marketCap":380858712},{"date":"2025-03-14","current":-2.331515,"twenty":-13.82213,"median":-4.821011,"eighty":-2.652983,"marketCap":356411700},{"date":"2025-03-21","current":-2.676613,"twenty":-13.82213,"median":-4.797324,"eighty":-2.63485,"marketCap":409165779},{"date":"2025-03-28","current":-1.691821,"twenty":-13.82213,"median":-4.768576,"eighty":-2.602098,"marketCap":258623652},{"date":"2025-04-04","current":-1.512581,"twenty":-13.82006,"median":-4.749792,"eighty":-2.558775,"marketCap":224922283},{"date":"2025-04-11","current":-1.63776,"twenty":-13.805931,"median":-4.730006,"eighty":-2.526789,"marketCap":243536541},{"date":"2025-04-17","current":-1.616897,"twenty":-13.782525,"median":-4.712385,"eighty":-2.472835,"marketCap":240434164},{"date":"2025-04-25","current":-1.543876,"twenty":-13.782525,"median":-4.704656,"eighty":-2.419894,"marketCap":229575847},{"date":"2025-05-02","current":-1.470854,"twenty":-13.74292,"median":-4.683117,"eighty":-2.321199,"marketCap":218717530},{"date":"2025-05-09","current":-1.262223,"twenty":-13.74292,"median":-4.673932,"eighty":-1.691821,"marketCap":187693767},{"date":"2025-05-16","current":-3.774812,"twenty":-13.703315,"median":-4.672091,"eighty":-1.683404,"marketCap":293174562}],"updateTime":1747667707442}}}